A+ | A | A- | Skip to main content |

Sensex

Nifty

USDINR

GBPINR

EURINR

Friday, 29 May 2026 12:00 AM EOD	Asian-Paints2672.10	Hind-Unilever2145.95	ITC287.00	Trent4230.60	Larsen-and-Toubro4076.65	M-and-M3034.80	Reliance-Industries1320.55	Tata-Steel208.90	Titan-Company4074.65	SBI964.00	Bharat-Electron410.90	Kotak-Mah-Bank384.70	Infosys1159.75	Bajaj-Finance904.70	Sun-PharmaInds1800.90	HDFC-Bank744.75	TCS2253.90	ICICI-Bank1256.00	Power-Grid-Corpn289.75	Maruti-Suzuki13119.85	Axis-Bank1287.90	HCL-Technologies1184.35	NTPC386.75	Bharti-Airtel1829.70	Tech-Mahindra1483.20	Adani-Ports1804.75	UltraTech-Cem11449.30	Bajaj-Finserv1784.65	Interglobe-Aviat4405.95	Eternal250.90
15 mins delay SENSEX 74,775.74 [-1,092.06]	-0.30 -0.01%	-51.90 -2.36%	-5.00 -1.71%	-17.95 -0.42%	30.85 0.76%	-84.80 -2.72%	-29.45 -2.18%	-5.85 -2.72%	-65.60 -1.58%	-3.65 -0.38%	-8.15 -1.94%	-3.65 -0.94%	0.60 0.05%	-26.25 -2.82%	-44.10 -2.39%	-13.75 -1.81%	-27.10 -1.19%	-16.80 -1.32%	-10.40 -3.46%	-246.00 -1.84%	-15.50 -1.19%	19.20 1.65%	-11.40 -2.86%	-21.55 -1.16%	28.50 1.96%	-19.55 -1.07%	-242.25 -2.07%	-23.65 -1.31%	-162.05 -3.55%	-5.65 -2.20%

Hot Pursuit

Scrips, which has significant changes during the market hours.

Natco Pharma tanks after Q4 profit declines 34% YoY to Rs 268 cr

29-May-26 15:23Hrs IST

Revenue from operations fell 39.46% YoY to Rs 739.1 crore in the quarter ended 31 March 2026.

Profit before tax (PBT) declined sharply by 71.51% to Rs 144.1 crore in Q4 FY26 from Rs 505.9 crore recorded in Q4 FY25.

On the segmental front, revenue from the pharmaceuticals business stood at Rs 716.5 crore, down 40.58% year-on-year. Meanwhile, revenue from the agro chemicals segment increased 50.66% YoY to Rs 716.5 crore in Q4 FY26.

For the full financial year FY26, Natco Pharma reported a 24.76% decline in consolidated net profit to Rs 1,418.5 crore. Revenue from operations decreased 7.92% year-on-year to Rs 4,078.3 crore in FY26.

NATCO Pharma, headquartered at Hyderabad, India, develops, manufactures and distributes generic and branded pharmaceuticals, specialty pharmaceuticals, active pharmaceutical ingredients and crop protection products.

Powered by Capital Market - Live News

Attention Investor :

"Prevent unauthorised transactions in your account ; Update your mobile numbers/email IDs with Us. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day” - Issued in the interest of Investors"

"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."

"No need to issue cheques by investors while subscribing to Equity IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

"Contents which are exclusively for Non-Broking Products/Services, "Mutual Fund, Mutual Fund-SIP, Research reports, Insurance, etc. where the Member is just a distributor. These are not Exchange traded product and the Member is just acting as distributor. It should also state that all disputes with respect to the distribution activity, would not have access to Exchange investor redressal forum or Arbitration mechanism."

A Muthoot M George Enterprise